Simons Svirskis Selected Research

Simons Svirskis Research Topics

Disease

5	Inflammation (Inflammations) 01/2023 - 10/2006
3	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2023 - 11/2021
3	Infections 01/2022 - 05/2020
3	Aortic Valve Stenosis (Aortic Stenosis) 08/2021 - 04/2019
2	Epilepsy (Aura) 09/2022 - 05/2020
2	Pathologic Constriction (Stenosis) 01/2021 - 04/2019
1	Chronic Disease (Chronic Diseases) 01/2023
1	Migraine Disorders (Migraine) 09/2022
1	Disease Progression 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Thyroid Diseases (Thyroid Disease) 01/2021
1	Osteoarthritis 08/2020
1	Synovitis 08/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 07/2020
1	Hepatolenticular Degeneration (Wilson's Disease) 04/2018
1	Brain Diseases (Brain Disorder) 01/2016
1	Amnesia (Dissociative Amnesia) 12/2014
1	Neuroinflammatory Diseases 01/2013
1	Stroke (Strokes) 01/2012
1	Ischemic Stroke 01/2012
1	Infarction (Infarctions) 01/2012
1	Parkinson Disease (Parkinson's Disease) 11/2010
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2010
1	Anxiety Disorders (Anxiety Disorder) 04/2009
1	Alcoholism (Alcohol Abuse) 04/2009
1	Cardiotoxicity 11/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2006
1	Muscular Diseases (Myopathy) 10/2006
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2006

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2010
5	CytokinesIBA 09/2022 - 05/2020
4	3-(2,2,2-trimethylhydrazine)propionateIBA 01/2013 - 10/2006
3	Proteins (Proteins, Gene)FDA Link 05/2020 - 01/2013
2	Matrix Metalloproteinases (MMPs)IBA 09/2022 - 04/2019
2	fibroblast growth factor 21IBA 01/2021 - 04/2019
2	AntigensIBA 08/2020 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 05/2020 - 01/2016
2	1,4-dihydropyridine (dihydropyridine)IBA 01/2012 - 11/2008
2	2,6- dimethyl- 3,5- bis(2'- propoxyethoxycarbonyl)- 4- (2''- difluoromethoxyphenyl)- 1,4- dihydropyridineIBA 01/2012 - 11/2008
2	Peptides (Polypeptides)IBA 11/2010 - 04/2009
2	Anti-HIV Agents (AIDS Drugs)IBA 11/2008 - 10/2006
2	Zidovudine (Retrovir)FDA LinkGeneric 11/2008 - 10/2006
1	Plasminogen Activator Inhibitor 1IBA 09/2022
1	Interleukin-8 (Interleukin 8)IBA 09/2022
1	AutoantibodiesIBA 01/2022
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2022
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2022
1	activin BIBA 11/2021
1	ThioredoxinsIBA 08/2021
1	Growth Differentiation Factor 15IBA 01/2021
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	SeleniumIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2020
1	Interleukin-6 (Interleukin 6)IBA 08/2020
1	Chemokine ReceptorsIBA 07/2020
1	EnzymesIBA 05/2020
1	AntibodiesIBA 05/2020
1	ImmunosorbentsIBA 05/2020
1	Tissue Inhibitor of Metalloproteinase-1IBA 04/2019
1	Metalloproteases (Metalloproteinases)IBA 04/2019
1	CopperIBA 04/2018
1	CurcuminIBA 04/2018
1	DNA Restriction Enzymes (Restriction Endonuclease)IBA 01/2016
1	Haloperidol (Haldol)FDA LinkGeneric 12/2014
1	Endothelin-1 (Endothelin 1)IBA 01/2012
1	gamma-butyrobetaine (butyrobetaine)IBA 01/2012
1	UbiquitinIBA 11/2010
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 11/2010
1	Oxidopamine (6 Hydroxydopamine)IBA 11/2010
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2010
1	NeurotoxinsIBA 11/2010
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2010
1	Glial Fibrillary Acidic ProteinIBA 11/2010
1	tauropyroneIBA 11/2008
1	glutapyroneIBA 11/2008
1	NucleosidesIBA 10/2006
1	Reverse Transcriptase InhibitorsIBA 10/2006

Therapy/Procedure

1	Therapeutics 10/2006